Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Rosenberg

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Plos One|June 4, 2015
Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothelial TumorsJoaquim Bellmunt, Lillian Werner, Jeffrey J Leow, et al.
The Journal of Invasive Cardiology|May 5, 2016
Transcatheter Therapy for a Large Mobile Right Atrial Thrombus and Massive Pulmonary EmbolismAkhil Narang, Anuj Mediratta, Jeremy R Estrada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2014
Phase I dose-escalation study of MEDI-573, a bispecific, antiligand monoclonal antibody against IGFI and IGFII, in patients with advanced solid tumorsPaul Haluska, Michael Menefee, Elizabeth R Plimack, et al.
Cancer Letters|January 24, 2009
Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancerPamela L Paris, Yasuko Kobayashi, Qiang Zhao, et al.
BJR Artificial Intelligence|May 1, 2026
AI-BLADE toolbox: AI-powered BLADdEr multiparametric MRI analysis for clinical applicationMuhammad Awais, Ramesh Paudyal, Oguz Akin, et al.
Cancers|November 25, 2023
Multiparametric MRI in Era of Artificial Intelligence for Bladder Cancer TherapiesOguz Akin, Alfonso Lema-Dopico, Ramesh Paudyal, et al.
Nature Genetics|November 8, 2016
Clonal evolution of chemotherapy-resistant urothelial carcinomaBishoy M Faltas, Davide Prandi, Scott T Tagawa, et al.
Tomography (Ann Arbor, Mich.)|November 21, 2023
A Quantitative Multiparametric MRI Analysis Platform for Estimation of Robust Imaging Biomarkers in Clinical OncologyEve LoCastro, Ramesh Paudyal, Amaresha Shridhar Konar, et al.
European Urology|February 16, 2022
Health-related Quality of Life of Patients with Locally Advanced or Metastatic Urothelial Cancer Treated with Enfortumab Vedotin after Platinum and PD-1/PD-L1 Inhibitor Therapy: Results from Cohort 1 of the Phase 2 EV-201 Clinical TrialBradley McGregor, Peter H O'Donnell, Arjun Balar, et al.
JAMA Ophthalmology|September 2, 2021
Clinical and Morphologic Characteristics of Fibroblast Growth Factor Receptor Inhibitor-Associated RetinopathyJasmine H Francis, James J Harding, Alison M Schram, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Plos One|June 4, 2015
Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothelial TumorsJoaquim Bellmunt, Lillian Werner, Jeffrey J Leow, et al.
The Journal of Invasive Cardiology|May 5, 2016
Transcatheter Therapy for a Large Mobile Right Atrial Thrombus and Massive Pulmonary EmbolismAkhil Narang, Anuj Mediratta, Jeremy R Estrada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2014
Phase I dose-escalation study of MEDI-573, a bispecific, antiligand monoclonal antibody against IGFI and IGFII, in patients with advanced solid tumorsPaul Haluska, Michael Menefee, Elizabeth R Plimack, et al.
Cancer Letters|January 24, 2009
Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancerPamela L Paris, Yasuko Kobayashi, Qiang Zhao, et al.
BJR Artificial Intelligence|May 1, 2026
AI-BLADE toolbox: AI-powered BLADdEr multiparametric MRI analysis for clinical applicationMuhammad Awais, Ramesh Paudyal, Oguz Akin, et al.
Cancers|November 25, 2023
Multiparametric MRI in Era of Artificial Intelligence for Bladder Cancer TherapiesOguz Akin, Alfonso Lema-Dopico, Ramesh Paudyal, et al.
Nature Genetics|November 8, 2016
Clonal evolution of chemotherapy-resistant urothelial carcinomaBishoy M Faltas, Davide Prandi, Scott T Tagawa, et al.
Tomography (Ann Arbor, Mich.)|November 21, 2023
A Quantitative Multiparametric MRI Analysis Platform for Estimation of Robust Imaging Biomarkers in Clinical OncologyEve LoCastro, Ramesh Paudyal, Amaresha Shridhar Konar, et al.
European Urology|February 16, 2022
Health-related Quality of Life of Patients with Locally Advanced or Metastatic Urothelial Cancer Treated with Enfortumab Vedotin after Platinum and PD-1/PD-L1 Inhibitor Therapy: Results from Cohort 1 of the Phase 2 EV-201 Clinical TrialBradley McGregor, Peter H O'Donnell, Arjun Balar, et al.
JAMA Ophthalmology|September 2, 2021
Clinical and Morphologic Characteristics of Fibroblast Growth Factor Receptor Inhibitor-Associated RetinopathyJasmine H Francis, James J Harding, Alison M Schram, et al.
Pageof 8